Guangzhou Pharmaceutical Holdings has a total of 240 patents globally, out of which 144 have been granted. Of these 240 patents, more than 62% patents are active. China is where Guangzhou Pharmaceutical Holdings has filed the maximum number of patents, it also seems reasonable as the biggest market for Guangzhou Pharmaceutical Holdings is China. Parallelly, China seems to be the main focused R&D center and is also the origin country of Guangzhou Pharmaceutical Holdings.
Guangzhou Pharmaceutical Holdings Limited (GPHL) was founded in 1996 and it is a wholly state-owned enterprise. It is dedicated to the research and development of Chinese patent medicine, herbal medicine, chemical-pharmaceutical raw materials and preparations, biological medicine and healthcare products. GPHL also provides pharmaceutical logistics and distribution and healthcare services.
Do read about some of the most popular patents of Guangzhou Pharmaceutical Holdings which have been covered by us in this article and also you can find Guangzhou Pharmaceutical Holdings patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over the Guangzhou Pharmaceutical Holdings patent portfolio.
How many patents does Guangzhou Pharmaceutical Holdings have?
Guangzhou Pharmaceutical Holdings has a total of 240 patents globally. These patents belong to 233 unique patent families. Out of 240 patents, 149 patents are active.
How many Guangzhou Pharmaceutical Holdings patents are Alive/Dead?
How Many Patents did Guangzhou Pharmaceutical Holdings File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Guangzhou Pharmaceutical Applications Filed||Guangzhou Pharmaceutical Patents Granted|
How Many Patents did Guangzhou Pharmaceutical Holdings File in Different Countries?
Countries in which Guangzhou Pharmaceutical Holdings Filed Patents
|United States Of America||1|
Where are Research Centers of Guangzhou Pharmaceutical Holdings Patents Located?
10 Best Guangzhou Pharmaceutical Holdings Patents
US6202923B1 is the most popular patent in the Guangzhou Pharmaceutical Holdings portfolio. It has received 15 citations so far from company like Kaiping Jianzhiyuan Food Co.
Below is the list of 10 most cited patents of Guangzhou Pharmaceutical Holdings:
|Publication Number||Citation Count|
GPHL has continuously improved its talent gathering ability and independent innovation ability with 3 Nobel Prize winners, 20 domestic academicians and masters of Chinese medicine, 2 experts enjoying special allowances from the State Council, and nearly 100 doctors and postdoctoral fellows strong high-level talent team. GPHL believes that innovation can lead to the future and dares to sail into the blue ocean.
EXCLUSIVE INSIGHTS COMING SOON!
What are Guangzhou Pharmaceutical Holdings key innovation segments?
What Technologies are Covered by Guangzhou Pharmaceutical Holdings?
The chart below distributes patents filed by GPHL in different countries on the basis of the technology protected in patents. It also represents the markets where GPHL thinks it’s important to protect particular technology inventions.
R&D Focus: How Guangzhou Pharmaceutical Holdings search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Guangzhou Pharmaceutical Holdings?